Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132304) titled 'Comparative Effect of Proton Pump Inhibitors and gastric mucosal protective agents on Acute Graft-versus-Host Disease Post-Transplantation' on Sept. 11.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The FIrst Affiliated Hospital, College of Medicine, Zhejiang University
Condition:
Acute graft-versus-host disease (aGVHD)
Intervention:
GMPA group:Intravenous PPI is permitted during the conditioning. From Day 0 through Day +100 post-transplantation, patients will receive oral teprenone.
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-09-15
Target S...